Influence of intravenous alteplase on endovascular treatment decision-making in acute ischemic stroke due to primary medium-vessel occlusion: a case-based survey study

BACKGROUND: Intravenous alteplase is currently the only evidence-based treatment for medium-vessel occlusion stroke (MeVO; M2/3, A2/3, and P2/3 vessel segment occlusions), but due to its limited efficacy, endovascular treatment (EVT) is increasingly performed in these patients. In this case-based su...

Descripción completa

Detalles Bibliográficos
Autores principales: Kappelhof, Manon, Ospel, Johanna, Kashani, Nima, Cimflova, Petra, Singh, Nishita, Almekhlafi, Mohammed A, Menon, Bijoy K, Fiehler, Jens, Chen, Michael, Sakai, Nobuyuki, Goyal, Mayank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Ischemic Stroke
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016248/
https://www.ncbi.nlm.nih.gov/pubmed/34035152
http://dx.doi.org/10.1136/neurintsurg-2021-017471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016248/
https://www.ncbi.nlm.nih.gov/pubmed/34035152
http://dx.doi.org/10.1136/neurintsurg-2021-017471

Ejemplares similares